Cancer Vaccine Breakthrough Shows Promise for Millions

Moderna and Merck just achieved the first successful late-stage trial of an mRNA cancer vaccine for melanoma, opening doors for more affordable universal cancer treatments.

The breakthrough validates technology that could one day make fighting cancer as simple as getting a shot.